) We propose to establish an interdisciplinary functional onco-imaging pre- center where a broad spectrum of researchers including imaging scientists, microbiologists, chemists, clinical scientists among others will exchange ideas and collaborate with each other to advance the field of cancer research and clinical practice. The long-term objective of this partnership is to understand the initiation and progression of cancer through the development of image based measurement techniques and image contrast agents. The immediate objective for the In Vivo Molecular and Functional Onco-Imaging Pre-Center is to develop core technologies to be employed at the full center and build the necessary infrastructure for the successful implementation of the pilot research projects. Along with these, other immediate objectives include; 1) developing the necessary organizational structure, 2) disseminating the available technology and opportunities to the university researchers and clinicians via monthly colloquia, 3) establishing joint operation of core facilities when feasible, and 4) formulating the policies for project selection, funding, and monitoring. Towards this goal we will focus on: 1. Integration of multi-modality equipment and techniques, 2. The initial modalities to be integrated are MR and Optical Imaging, 3. Using information obtained from such systems to understand the underlying mechanisms by analyzing the factors that contribute to bulk signal intensities. 4. Developing imaging agents to label various molecular markers associated with angiogenesis, 5. Developing imaging agents to quantify tumor vascular properties with an ultimate goal of detecting angiogenesis, 6. Exploiting the above mentioned agents and image based measurement techniques to assess therapeutic efficacy, 7. Developing imaging/therapeutic agents to monitor therapy. The initial scientific areas that would be participating at the center include image science (MR and optics). molecular biology, contrast agent development, immunohistochemistry, pathology, and oncology. As our track record indicates we already have had fairly strong collaborations among the initial members of the center. What is new in the present application is to form the necessary administrative structure as well as the infrastructure to elevate such collaborations to the next level to fulfill our vision in developing a Molecular and Functional Onco-Imaging Center to fight against cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory Grants (P20)
Project #
5P20CA086182-02
Application #
6377871
Study Section
Special Emphasis Panel (ZCA1-SRRB-3 (J2))
Project Start
2000-04-01
Project End
2003-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
2
Fiscal Year
2001
Total Cost
$363,396
Indirect Cost
Name
University of California Irvine
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Gulsen, Gultekin; Birgul, Ozlem; Unlu, Mehmet Burcin et al. (2006) Combined diffuse optical tomography (DOT) and MRI system for cancer imaging in small animals. Technol Cancer Res Treat 5:351-63
Gulsen, Gultekin; Xiong, Bin; Birgul, Ozlem et al. (2006) Design and implementation of a multifrequency near-infrared diffuse optical tomography system. J Biomed Opt 11:014020
Hsiang, David; Shah, Natasha; Yu, Hon et al. (2005) Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer. Technol Cancer Res Treat 4:549-58
Muftuler, L Tugan; Hamamura, Mark; Birgul, Ozlem et al. (2004) Resolution and contrast in magnetic resonance electrical impedance tomography (MREIT) and its application to cancer imaging. Technol Cancer Res Treat 3:599-609
Shah, Natasha; Cerussi, Albert E; Jakubowski, Dorota et al. (2004) Spatial variations in optical and physiological properties of healthy breast tissue. J Biomed Opt 9:534-40
Cuccia, David J; Bevilacqua, Frederic; Durkin, Anthony J et al. (2003) In vivo quantification of optical contrast agent dynamics in rat tumors by use of diffuse optical spectroscopy with magnetic resonance imaging coregistration. Appl Opt 42:2940-50
Merritt, S; Gulsen, G; Chiou, G et al. (2003) Comparison of water and lipid content measurements using diffuse optical spectroscopy and MRI in emulsion phantoms. Technol Cancer Res Treat 2:563-9
Shah, Natasha; Cerussi, Albert E; Jakubowski, Dorota et al. (2003) The role of diffuse optical spectroscopy in the clinical management of breast cancer. Dis Markers 19:95-105
Samoszuk, Michael; Corwin, Mark; Yu, Hon et al. (2003) Inhibition of thrombosis in melanoma allografts in mice by endogenous mast cell heparin. Thromb Haemost 90:351-60
Merritt, Sean; Bevilacqua, Frederic; Durkin, Anthony J et al. (2003) Coregistration of diffuse optical spectroscopy and magnetic resonance imaging in a rat tumor model. Appl Opt 42:2951-9

Showing the most recent 10 out of 15 publications